TreatmentUpdate40: (CATIE) - February 1993
Sean Hosein
SUBJECTS AND BACTERIA
The researchers enrolled 25 healthy subjects who were at least 70 years old. Subjects were randomly assigned to receive capsules of friendly bacteria (2 capsules 4 times daily) or placebo. Capsules containing millions of bacteria (brand name Infloran(R)) were supplied by the Instituto Sieroterapico Berna in Como, Italy. The bacteria inside the capsules were Bifidobacterium bifidum and Lactobacillus acidophilus. Fifteen subjects received bacteria and 10 were given placebo.
RESULTS
The researchers found that there were no significant changes in T-cell numbers or side effects as a result of receiving the bacteria. However, subjects given bacteria had statistically significant increases in the number of B-cells compared with others who received placebo. There were no changes in other types of blood cells. In subjects who had inflammation of their intestine, use of friendly bacteria decreased the inflammation by 50% compared with subjects on placebo who did not have a reduction in inflammation. Along with the reduction in inflammation, the numbers of white blood cells in those tissues were reduced in subjects given bacteria. This marked withdrawal of white blood cells (which were no longer needed) in those given bacteria compared to those given placebo was statistically significant.
HOW BACTERIA CAN HELP
Use of friendly bacteria may produce a "barrier" against other, less welcome microorganisms. In experiments with animals, oral use of bacterial products have been found to stimulate the immune system. This is why some vaccines can be given orally. For people with HIV infection, friendly bacteria may be one way to keep the growth of yeast such as Candida in check. High doses of bacteria, such as those used in this study, have potential to increase levels of antibody-producing B-cells and perhaps delay the appearance of life-threatening diarrhea caused by C. parvum, commonly called 'crypto'. More information on this is presented in the section on infection fighters.
REFERENCES:
1. DeSimone C, Ciardi A, Grassi A, etal. Effect of Bifdobacterium bifidum and Lactobacillus acidophilus on gut mucosa and peripheral blood lymphocytes. Immunopharmacology and Immunotoxicology 1992;14(1 & 2):331-340.
2. Kendig NE, Chrest FJ, Nagel TE, et al. Age-related changes in the immune function of HIV-1 seropositive adults . Aging:Immunology and Infectious Disease 1991;3(2):67-80.
930201
CATI4009
Copyright © 1993 - TreatmentUpdate. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through the Editor, The Canadian AIDS Treatment Information Exchange, 555 Richmond St. West, Suite 505, Box 1104, Toronto, ON, M5V 3B1 • Phone: 416-203-7122 • Toll Free: 1-800-263-1638 • Fax: 416-203-8284 http://www.catie.ca